Abstract
A next generation DNA vaccine coding for the immunodominant sequence of alpha-Enolase enhances the ability to induce effector T cell responses and promotes anti-tumor immunity in pancreatic cancer
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have